Platelia Aspergillus Ag Assays
Immunosuppressed patients are an at-risk population for invasive aspergillosis (IA). IA mortality rates are high in part because diagnosing IA in a timely manner can be challenging. To initiate efficient treatment and avoid costly antifungal therapy, early and reliable IA diagnosis is essential.
Platelia Aspergillus Ag Assay
The Platelia Aspergillus Ag Assay aids in diagnosis by detecting circulating galactomannan (GM) Ag — the most relevant biomarker for invasive aspergillosis.
The highly sensitive assay is a noninvasive method that improves the rapid and specific diagnosis of IA when used alongside other diagnostic procedures.
It is the only Aspergillus Ag assay that is U.S. FDA 510(k) cleared and EU-IVDR certified for both adult and pediatric patient samples.
Aids in Diagnosing High-Risk Patients
- ICU patients
- Neutropenic and non-neutropenic patients with hematologic malignancies
- Solid organ and hematopoietic stem cell transplant recipients
- Pediatric patients with the pathologies above
Helps Monitor Infection and Treatment Efficacy
By providing semi-quantitative results expressed as GM index values, the assay enables the monitoring of:
- The course of the infection for rapid initiation of antifungal treatment
- Treatment efficacy and follow up of patient status
Your laboratory can assist physicians in making appropriate therapeutic decisions.
Performance
- Only Aspergillus Ag assay that is U.S. FDA 510(k) cleared and EU-IVDR certified for both adult and pediatric patient samples
- Provides semi-quantitative results
- Available in more than 80 countries
Confidence
- Gold standard assay for GM Ag detection
- Delivers reliable results with well-known test limitations: validated 0.5 cut-off index for serum and BAL fluid testing and no gray zone for result interpretation
Performance
- Only Aspergillus Ag assay that is U.S. FDA 510(k) cleared and EU-IVDR certified for both adult and pediatric patient samples
- Available in more than 80 countries
Confidence
- Gold standard assay for GM Ag detection
- Delivers reliable results with well-known test limitations: validated 0.5 cut-off index for serum and BAL fluid testing and no gray zone for result interpretation
Selection List of Scientific Publications
Learn the diverse and impactful ways the Bio-Rad Platelia Aspergillus Ag assay has been used since the COVID-19 pandemic, with over 22 references published between 2020 and 2023.
Reference List of Scientific Publications
Since 1998, the Platelia Aspergillus Ag Assay has been extensively studied by the global scientific community across various patient cohorts, resulting in over 270 published references.
Verification Panel Assay
The Platelia Aspergillus Ag Verification Panel Kit allows laboratories to periodically verify operator proficiency in running the Platelia Aspergillus Ag Assay during training — before testing patient specimens and before participating in external quality assurance (EQA). Labs can also ensure proper performance of equipment and troubleshoot issues.
